Blog
January 8, 2026 - Blog
Intellijoint: What to Expect in 2026
Hello everyone,
Armen here – CEO and Co-Founder of Intellijoint Surgical.
As we begin 2026, I want to start a new tradition: sharing with you, the Intellijoint community, what we accomplished last year and what you can expect from us in the year ahead.
Intellijoint has become a global community with a common goal: improving patients’ lives by providing every orthopaedic surgeon and their care team access to effective, easy-to-use technologies. As I travelled the world last year, I reflected on just how much our community has grown and how important it is for me to communicate with you.
So, whether you, reader, are a surgeon, healthcare worker, clinical researcher, past or current employee, business or government partner, institutional or individual investor, or simply someone who believes in what we do – I’m so grateful for your support and am excited by the opportunity ahead!
2025 – Intellijoint’s Best Year Yet
Simply put, 2025 was the best year in Intellijoint’s history.
This year, Intellijoint was used in more operating rooms, by more surgeons, in more geographies than ever before. Highlights from the year include:
- We surpassed our 80,000th patient served globally and are on track to serve our 100,000th patient in 2026.
- We expanded into new US cities, serving patients in Jackson, Riverside, and Portland for the first time, and began surgeries in India, including New Delhi, Bangalore, Hyderabad, and Chennai.
- We released the simplest and most efficient pre-operative planning tool for total knee arthroplasty, including a version that is free to all users.
- We launched a new business unit, IJX, to partner with other medical OEMs to bring Intellijoint’s core technology into new surgical areas like spine and shoulder.
As a small but growing Canadian medical technology company competing against global industry giants, I could not be prouder of our team and what they accomplished. 2025 was the culmination of steady progress, hard choices, and collective focus.
We proved that a small, aligned team can earn the trust of surgeons and healthcare leaders again and again – whether that means growing our presence in cities like New York or expanding into new countries like Saudi Arabia.
To everyone who played a role in 2025, thank you! This was truly a collective achievement.
2026 – Significant Global Expansion on the Horizon
In 2025, we steadily built our strongest global pipeline to date. In 2026, you should expect to see significant expansion as a result.
This includes continued growth in the Middle East and Asia as well as new opportunities in South America for the first time in our history. Since these opportunities are in active discussions, I’m not able to share where exactly we will be starting surgeries yet. But what I can share is that I will be joining the Government of Ontario’s Life Sciences Trade Mission to Brazil next month and am excited to meet potential partners and surgeons there this year.
At the same time, the United States remains a critical area of growth for Intellijoint. In 2026 we will continue investing in the country and are actively hiring three new Market Development Managers to accelerate adoption in new US cities. I also plan to travel to the US to meet with surgeons as we work on some exciting updates to our products this year.
We also continue to make good progress in our home country of Canada, with the Government of Ontario beginning to significantly support orthopaedic care and innovation. I believe 2026 will be a landmark year for Intellijoint in Canada, with new partnerships beginning that will benefit patients across the country.
Regardless of geography, I’m honoured to have opportunities as I travel to see first-hand the positive reaction to our simple, reliable, and efficient technology. That moment where it just clicks is so rewarding and I’m thrilled to experience it again this year with new customers.
Looking Ahead
Across the world, healthcare systems, hospitals, and surgical centres are under pressure to do more with less. The need for effective and easy-to-use innovation has never been clearer. As we start 2026, I’ve never been more optimistic for the year ahead.
Thank you again for being part of the Intellijoint community. I’m excited by what we’re building together and appreciate your continued support!
– Armen